BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2015
View Archived Issues
WOL-074-019 shows efficacy in inflammation models of colitis and psoriasis
Read More
Phase I/II and biomarker data of the hypoxia-activated prodrug PR-104 in AML and ALL
Read More
Scientists discover divergent urinary metabolic phenotypes between MDD and BD
Read More
Galera plans phase II trial of GC-4419 to protect against radiation-induced oral mucositis
Read More
VBL Therapeutics plans phase III study of VB-111 plus bevacizumab in recurrent glioblastoma
Read More
ImmunoCellular Therapeutics and FDA reach agreement on SPA for ICT-107
Read More
KH-176 receives European orphan drug designation for MELAS syndrome
Read More
Wilex confirms discontinuation of collaboration between Heidelberg Pharma and Roche
Read More
CFDA approves phase I/II/III clinical trials of pirotinib
Read More
Dong-A ST to commercialize Acelex in Korea
Read More
Merck & Co. and MD Anderson to evaluate pembrolizumab combination therapies for solid tumors
Read More
HiFiBiO achieves milestone in Pfizer antibody research collaboration
Read More
DIAPH-3 expression predicts tumor response to chemotherapy
Read More
Topline results from phase I study of vonapanitase in symptomatic peripheral artery disease
Read More
Bioequivalence results announced for an agent for Fabry's disease
Read More
Hua Medicine reports phase Ic data on HMS-5552 in type 2 diabetes
Read More
LDL-cholesterol reductions observed in phase I study of CAT-2054
Read More
Bayer Schering Pharma presents antimitotics
Read More
Roche patents new anti-RSV compounds
Read More
AbbVie divulges TrKA inhibitors
Read More
Confluence Life Sciences introduces TAK1 inhibitors
Read More
Boehringer Ingelheim and Circuit Therapeutics collaborate on metabolic disorders
Read More
Redx Pharma patents antibacterial agents
Read More
HedgePath studies SUBA-Itraconazole in phase IIb study for basal cell carcinoma nevus syndrome
Read More
Phase Ib/II trial investigates talimogene laherparepvec with radiotherapy for soft tissue sarcomas
Read More
FDA approves Octapharma's WILATE supplement for the management of VWD
Read More